![Larry Alphs](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Larry Alphs is the founder of International Society For Cns Clinical Trials & Methodology.
Dr. Alphs is Senior Vice President-CNS Development at Denovo Biopharma LLC.
Dr. Alphs was Chief Medical Officer at NetraMark Holdings, Inc. from 2023 to 2026.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 23/12/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Denovo Biopharma LLC
 Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Manufactures personalize and clinical drugs | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
| NETRAMARK HOLDINGS INC. | Director Técnico/Científico/I+D | 04/05/2026 |
International Society For Cns Clinical Trials & Methodology | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Denovo Biopharma LLC
Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Manufactures personalize and clinical drugs | Health Technology |
International Society For Cns Clinical Trials & Methodology | |
NetraMark Holdings, Inc.
 NetraMark Holdings, Inc. Packaged SoftwareTechnology Services Develops app that provides brain health solutions | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
